The Folly of ‘America First’ in the Race for Biodata Amid a Pandemic
By Tamsin Shaw,
The New York Review of Books
| 05. 13. 2020
Genomic biodata is essential for epidemiology, as well as for the development of vaccines and treatments. America’s response to the coronavirus pandemic has exposed its shocking lack of preparedness for a public health emergency.
America’s response to the coronavirus pandemic has exposed a shocking lack of preparedness for public health emergencies. But it has also revealed what must be, for the aspiring strongman in the White House and his coterie, a more embarrassing fact: if America were to move in an authoritarian direction, it would be shedding international allies in order to enter into a competition with nationalistic authoritarian states that it probably can’t win.
The strengths that the US has built over the seventy-five years since World War II lie elsewhere—and they are ones that the Trump administration clearly doesn’t recognize. If the White House had chosen the standard liberal-democratic approach to a pandemic for which we were once well prepared, it would have prioritized public health goals: minimizing suffering and reducing mortality rates, and thereby also mitigating the damage to social, economic, and political institutions. That approach would have meant global cooperation, scientific collaboration, and humanitarian aid to poorer countries to help halt the spread of the virus.
But this administration did not choose that path. The president is a fan neither...
Related Articles
By Annalee Armstrong, BioSpace | 09.11.2024
Complex gene therapies are starting to hit the market but all have faced the same reality: a tepid reception from the healthcare system and a cloudy path to profitability.
It can take about a year for a patient to go...
By Julia Brown, The Conversation | 08.16.2024
With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in genomic medicine, which is geared toward benefiting future patients, time and...
By Smriti Mallapaty, Nature | 09.11.2024
Under his microscope, Jun Wu could see several tiny spheres, each less than 1 millimetre wide. They looked just like human embryos: a dark cluster of cells surrounded by a cavity, and then another ring of cells.
But Wu, a...
By Antonio Regalado, MIT Technology Review | 08.22.2024
In 2016, I attended a large meeting of journalists in Washington, DC. The keynote speaker was Jennifer Doudna, who just a few years before had co-invented CRISPR, a revolutionary method of changing genes that was sweeping across biology labs because...